Beranda › Mesotelioma
Uji klinis Mesotelioma yang merekrut di AS
45 studi untuk Mesotelioma merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX15 studi
- New York City, NY10 studi
- Washington, DC9 studi
- Chicago, IL9 studi
- Nashville, TN8 studi
- Boston, MA8 studi
- Arlington, VA6 studi
- Philadelphia, PA6 studi
- Pittsburgh, PA6 studi
- Seattle, WA6 studi
- Los Angeles, CA6 studi
- Rochester, MN5 studi
- Columbus, OH5 studi
- Edison, NJ5 studi
- San Antonio, TX4 studi
- San Diego, CA4 studi
- St. Louis, MO4 studi
- Tampa, FL4 studi
- Phoenix, AZ4 studi
- Jacksonville, FL4 studi
- Queens, NY4 studi
- Dallas, TX4 studi
- Omaha, NE4 studi
- Denver, CO3 studi
- Grand Rapids, MI3 studi
- Detroit, MI3 studi
- Santa Monica, CA3 studi
- Mountain View, CA3 studi
- New Rochelle, NY3 studi
- Greenburgh, NY3 studi
- Staten Island, NY3 studi
- East Norwalk, CT3 studi
- Miami, FL3 studi
- Santa Rosa, CA3 studi
- Fort Worth, TX3 studi
- Durham, NC3 studi
Berdasarkan negara bagian
- Arizona7 studi
- California12 studi
- Colorado8 studi
- Florida12 studi
- Georgia3 studi
- Illinois11 studi
- Kansas3 studi
- Maryland10 studi
- Massachusetts10 studi
- Michigan6 studi
- Minnesota8 studi
- Missouri5 studi
- Nebraska4 studi
- New Jersey8 studi
- New York11 studi
- North Carolina4 studi
- Ohio9 studi
- Pennsylvania13 studi
- Tennessee8 studi
- Texas19 studi
- Utah4 studi
- Virginia8 studi
- Washington6 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
SW-682 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06251310Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Menerima pesertaStudi observasional
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00242723Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Menerima pesertaStudi observasional
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06885697Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Menerima pesertaStudi observasional
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03830229Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05932199Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04431024A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Menerima peserta
Usia 30 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06037941A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06057935Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Menerima pesertaFase 2
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05960773A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05245500A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Menerima pesertaFase 1
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06756035A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.